Headlines about Telesta Therapeutics (TSE:TST) have trended somewhat positive this week, according to InfoTrie. InfoTrie scores the sentiment of press coverage by reviewing more than 6,000 news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Telesta Therapeutics earned a media sentiment score of 1.25 on their scale. InfoTrie also assigned news headlines about the biotechnology company an news buzz score of 10 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company’s share price in the near future.
Telesta Therapeutics has a 52-week low of C$0.69 and a 52-week high of C$0.14.
About Telesta Therapeutics
Recommended Story: What are the economic characteristics of a bear market?
Receive News & Ratings for Telesta Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telesta Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.